A Prospective Cohort Study Comparing the Effectiveness of Zepatier for the Treatment of Hepatitis C in an Academic Center Population to People Who Inject Drugs (PWIDs) in a Safety Net Clinic Setting Engaged in Either a Medication Assisted Therapy (MAT) or Syringe Exchange Program
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Nov 2018 Preliminary results (n=45) presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases
- 20 Aug 2018 Status changed from not yet recruiting to recruiting.
- 20 Aug 2018 Planned End Date changed from 30 Jan 2019 to 30 Mar 2019.